Commodore Capital’s Relmada Therapeutics RLMD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-161,565	Closed	-$5.69M	–	30
2021 Q1	$5.69M	Sell	161,565 -17,000	-10%	-$599K	2.27%	19
2020 Q4	$5.73M	Buy	+178,565	New	+$5.73M	3.11%	17